Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo

被引:147
作者
Kim, S
Li, Q
Dang, CV
Lee, LA [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Grad Program Mol Med, Baltimore, MD 21205 USA
关键词
D O I
10.1073/pnas.200372597
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Overexpression of c-Myc in immortalized cells increases cell proliferation, inhibits cell differentiation, and promotes cell transformation. Recent evidence suggests that these effects, however, do not necessarily occur when c-Myc is overexpressed in primary mammalian cells. We sought to determine the immediate effects of transient overexpression of c-Myc in primary cells in vivo by using recombinant adenovirus to overexpress human MYC in mouse liver. Mice were intravenously injected with adenoviruses encoding MYC(Ad/Myc). E2F-1 (Ad/E2F-1), or beta-galactosidase (Ad/LacZ), Transgene expression was detectable 4 days after injection. Expression of ectopic c-Myc was immediately accompanied by enlarged and dysmorphic hepatocytes in the absence of significant cell proliferation or apoptosis, These findings were not present in the livers of mice injected with Ad/E2F-1 or Ad/LacZ. Prominent hepatocyte nuclei and nucleoli were associated with the upregulation of large- and small-subunit ribosomal and nucleolar genes, suggesting that c-Myc may induce their expression to increase cell mass. Our studies support a role for c-Myc in the in vivo control of vertebrate cell size and metabolism independent of cell proliferation.
引用
收藏
页码:11198 / 11202
页数:5
相关论文
共 47 条
[1]   THE C-MYC PROTEIN INDUCES CELL-CYCLE PROGRESSION AND APOPTOSIS THROUGH DIMERIZATION WITH MAX [J].
AMATI, B ;
LITTLEWOOD, TD ;
EVAN, GI ;
LAND, H .
EMBO JOURNAL, 1993, 12 (13) :5083-5087
[2]   THE ORNITHINE DECARBOXYLASE GENE IS A TRANSCRIPTIONAL TARGET OF C-MYC [J].
BELLOFERNANDEZ, C ;
PACKHAM, G ;
CLEVELAND, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7804-7808
[3]   BINDING OF MYC PROTEINS TO CANONICAL AND NONCANONICAL DNA-SEQUENCES [J].
BLACKWELL, TK ;
HUANG, J ;
MA, A ;
KRETZNER, L ;
ALT, FW ;
EISENMAN, RN ;
WEINTRAUB, H .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (09) :5216-5224
[4]   MYC AND MAX ASSOCIATE INVIVO [J].
BLACKWOOD, EM ;
LUSCHER, B ;
EISENMAN, RN .
GENES & DEVELOPMENT, 1992, 6 (01) :71-80
[5]   Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 [J].
Bouchard, C ;
Thieke, K ;
Maier, A ;
Saffrich, R ;
Hanley-Hyde, J ;
Ansorge, W ;
Reed, S ;
Sicinski, P ;
Bartek, J ;
Eilers, M .
EMBO JOURNAL, 1999, 18 (19) :5321-5333
[6]   A novel role for the cyclin-dependent kinase inhibitor p27Kip1 in angiotensin II-stimulated vascular smooth muscle cell hypertrophy [J].
Braun-Dullaeus, RC ;
Mann, MJ ;
Ziegler, A ;
von der Leyen, HE ;
Dzau, VJ .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (06) :815-823
[7]   The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation [J].
Cole, MD ;
McMahon, SB .
ONCOGENE, 1999, 18 (19) :2916-2924
[8]   Function of the c-Myc oncogenic transcription factor [J].
Dang, CV ;
Resar, LMS ;
Emison, E ;
Kim, S ;
Li, Q ;
Prescott, JE ;
Wonsey, D ;
Zeller, K .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) :63-77
[9]   E2F-1 ACCUMULATION BYPASSES A G(1) ARREST RESULTING FROM THE INHIBITION OF G(1) CYCLIN-DEPENDENT KINASE-ACTIVITY [J].
DEGREGORI, J ;
LEONE, G ;
OHTANI, K ;
MIRON, A ;
NEVINS, JR .
GENES & DEVELOPMENT, 1995, 9 (23) :2873-2887
[10]  
Derenzini M, 1998, AM J PATHOL, V152, P1291